News

News - 2019

November 2019

Availability of Stannous PYP Kit

The Calgary Radiopharmaceutical Centre (CRC) holds a Drug Establishment Licence and produces a few niche radiopharmaceutical products. At this time the CRC is the only supplier in Canada of a stannous pyrophosphate kit (Stannous PYP Kit) for the preparation of Technetium Tc99m pyrophosphate.

           Information Letter

           Order Form

           Product Package Insert

*************************

March 2019

European School of Medical Imaging Technology (ESMIT)

Because the CANM is an affiliate member of the EANM, our members are given access to the highly regarded European School of Medical Imaging Technology (ESMIT). The European Nuclear Medicine practice is dynamic and has much experience with many procedures which are now finding their way to Canada. As well, they offer perspectives on established practice.

https://www.eanm.org/esmit/

*************************

Availability of Choletec™ (Mebrofenin) – Kit For The Preparation of Technetium Tc-99

BRACCO IMAGING Canada is pleased to inform you that a new lot of Canadian Choletec™ (Mebrofenin) was received at our Montreal facility. We immediately shipped and fulfilled the request for products to Canadian facilities who had an order with BRACCO.

• BRACCO IMAGING Canada Letter

*************************

Stannous DISIDA Kits by the Calgary Radiopharmaceutical Centre

Alberta Health Services

The Calgary Radiopharmaceutical Centre (CRC) has Stannous DISIDA Kits available for distribution to Nuclear Medicine departments performing hepatobiliary imaging. This product is being offered to the Nuclear Medicine community-at-large to help mitigate the interim shortage of DISIDA and Mebrofenin kits in Canada.

• Alberta Health Services Letter - Acces to Stannous DISIDA Kit
• DISIDA Kit insert
• 3rd Party Cold Kit Order Form

*************************

Past News - 2018

October 2018

Quality Control in the Production of Radiopharmaceuticals

Advances have led to the production of new radiopharmaceuticals and availability of new production routes. Various new diagnostic agents in the field (such as Ga-68 radiopharmaceuticals and generators) as well as therapeutic agents (such as alpha emitters) have been added to the clinician’s menu. It is essential that radiopharmaceuticals are prepared within a robust quality control system encompassing materials and personnel, with adequate documentation, and continuous review of ongoing results. This publication provides guidelines and best practices for the quality control of medical radioisotopes and radiopharmaceuticals. It was written by a group of experts with experience across a range of radiopharmaceuticals and is intended to support professionals in the preparation of good quality and safe products to be used in nuclear medicine procedures.

Click here for more information.

June 2018

Darlington to supply moly-99

Ontario Power Generation's (OPG) Darlington nuclear power plant is to produce molybdenum-99 (Mo-99) for use in new technetium-99m (Tc-99m) generators designed by BWX Technologies Inc. The Candu plant will be the first large-scale commercial nuclear power plant in the world to produce Mo-99.

http://www.world-nuclear-news.org/RS-Darlington-to-supply-molybdenum-99-2106187.html

April 2018

Mo-99 Production Activities at NTP Radioisotopes (NTP) and I-131 Supply Situation

NTP reported that it received approval from the South African Nuclear Regulator to return to normal operations through the end of June 2018. During this period, NTP will engage with the NNR to ensure continued normal operation from July 2018 onwards. NTP also stated that as a result of this approval, NTP will be in a position to manufacture I-131 to assist with the international shortage.

March 2018

Emeritus Winner

Dr. John Powe - Vancouver

2018 Eric Lepp Recipient 

Dr. Caroline Malo Pion, Montréal

Past News - 2017

July 2017

Beta, BTG’s Education, Training and Audit program

Beta, BTG’s Education, Training and Audit program is designed to reduce the risk of radiation exposure when performing selective internal radiation therapy (SIRT) by increasing awareness of radiation safety and providing risk education.

For more information, click here:

IAEA Webinars and E-Learning Modules

Free IAEA Webinars and e-learning modules available

For more information, click here:

May 2017

Hermes - News Letter and Press Release

The Board of Directors for Hermes Medical Solutions AB has appointed Mikael Strindlund as new President and CEO. Hermes Medical Solutions is a global leader in digital medical imaging with a focus on end-to-end clinical IT-solutions within molecular imaging and radiology. 

Click here to view Newsletter

Click here  to view Press Release.

********************

Le Patient March-April 2017

To view all Le Patient editions, click here.

Past News - 2016

November 2016

Canada 2020-A New Health Accord for all Canadians - November 2016

Conference Report - The presentations and debates heard at Canada 2020’s Health Summit included many recommendations about how Canada’s health system can be improved.
Click here to view report

 ************************

************************

September 2016

Lantheus letter on Mo99 supply - September 28, 2016

Read full letter by clicking here.

*******************